Ismail Alay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ismail Alay has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Cihan Kaya
Department of Obstetrics and Gynecology, Istanbul Aydın University Faculty of Medicine, Istanbul, Turkiye
24 shared publications - Şükrü Yıldız
University of Health Sciences Turkey, Turkey
12 shared publications - Hüseyin Cengiz
Department of Obstetrics and Gynecology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
9 shared publications Murat Ekin
Department of Obstetrics and Gynecology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
8 shared publications- Levent Yaşar
University of Health Sciences Turkey, Turkey
7 shared publications Huseyin Cengiz
Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Aydin University, Istanbul, Turkey
5 shared publications
Latest Publications
- Open Access
- 13 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7101
Phenotype-Specific Differences in Insulin Resistance and Androgenic Profiles in Polycystic Ovary Syndrome: A Prospective Observational Study
Background and Objectives: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine and metabolic disorder characterized by distinct phenotypic presentations. This study aimed to compare androgenic and metabolic characteristics across Rotterdam-defined PCOS phenotypes, with particular emphasis on insulin resistance. Materials and Methods: This prospective observational study included 261 nulliparous women with PCOS who were prospectively enrolled and classified according to the Rotterdam criteria as phenotype A (n = 101), B (n = 39), C (n = 55), or D (n = 66). Clinical hyperandrogenism, biochemical androgen parameters, hormonal parameters, lipid profiles, and insulin resistance assessed using the homeostasis model assessment of insulin resistance (HOMA-IR) were compared across phenotypes. Insulin resistance was defined as HOMA-IR ≥ 2.5. Multivariable logistic regression was performed to evaluate the association between PCOS phenotype and insulin resistance after adjustment for age and body mass index (BMI). Results: Significant differences were observed among phenotypes in sex hormone-binding globulin (SHBG), free androgen index (FAI), and Ferriman–Gallwey scores (p = 0.005, p < 0.001, and p < 0.001, respectively). Median HOMA-IR differed significantly among phenotypes (p < 0.001) and was lowest in phenotype D. The prevalence of insulin resistance was 58.3%, 56.4%, 49.1%, and 22.6% in phenotypes A, B, C, and D, respectively (p < 0.001). After adjustment for age and BMI, phenotypes A (adjusted odds ratio [aOR] 4.56, 95% CI 2.20–9.42), B (aOR 4.54, 95% CI 1.90–10.87), and C (aOR 3.29, 95% CI 1.47–7.38) were associated with higher odds of insulin resistance compared with phenotype D. HDL-C also differed among phenotypes (p = 0.006), whereas other conventional lipid parameters, the TG/HDL ratio, and AIP were comparable. Conclusions: Rotterdam-defined PCOS phenotypes exhibit distinct androgenic and metabolic profiles. Hyperandrogenic phenotypes, particularly A and B, were associated with greater insulin resistance, whereas phenotype D showed a more favorable metabolic profile. These findings reflect cross-sectional metabolic differences between PCOS phenotypes and should not be interpreted as evidence of future cardiometabolic risk.
- 13 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7101
Open AccessPhenotype-Specific Differences in Insulin Resistance and Androgenic Profiles in Polycystic Ovary Syndrome: A Prospective Observational Study
Background and Objectives: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine and metabolic disorder characterized by distinct phenotypic presentations. This study aimed to compare androgenic and metabolic characteristics across Rotterdam-defined PCOS phenotypes, with particular emphasis on insulin resistance. Materials and Methods: This prospective observational study included 261 nulliparous women with PCOS who were prospectively enrolled and classified according to the Rotterdam criteria as phenotype A (n = 101), B (n = 39), C (n = 55), or D (n = 66). Clinical hyperandrogenism, biochemical androgen parameters, hormonal parameters, lipid profiles, and insulin resistance assessed using the homeostasis model assessment of insulin resistance (HOMA-IR) were compared across phenotypes. Insulin resistance was defined as HOMA-IR ≥ 2.5. Multivariable logistic regression was performed to evaluate the association between PCOS phenotype and insulin resistance after adjustment for age and body mass index (BMI). Results: Significant differences were observed among phenotypes in sex hormone-binding globulin (SHBG), free androgen index (FAI), and Ferriman–Gallwey scores (p = 0.005, p < 0.001, and p < 0.001, respectively). Median HOMA-IR differed significantly among phenotypes (p < 0.001) and was lowest in phenotype D. The prevalence of insulin resistance was 58.3%, 56.4%, 49.1%, and 22.6% in phenotypes A, B, C, and D, respectively (p < 0.001). After adjustment for age and BMI, phenotypes A (adjusted odds ratio [aOR] 4.56, 95% CI 2.20–9.42), B (aOR 4.54, 95% CI 1.90–10.87), and C (aOR 3.29, 95% CI 1.47–7.38) were associated with higher odds of insulin resistance compared with phenotype D. HDL-C also differed among phenotypes (p = 0.006), whereas other conventional lipid parameters, the TG/HDL ratio, and AIP were comparable. Conclusions: Rotterdam-defined PCOS phenotypes exhibit distinct androgenic and metabolic profiles. Hyperandrogenic phenotypes, particularly A and B, were associated with greater insulin resistance, whereas phenotype D showed a more favorable metabolic profile. These findings reflect cross-sectional metabolic differences between PCOS phenotypes and should not be interpreted as evidence of future cardiometabolic risk.
- 25 March 2022
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 18 (1) , 82-85
Effects of Dienogest Only Treatment on Lipid Profile
- 25 March 2022
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 18 (1) , 82-85
Effects of Dienogest Only Treatment on Lipid Profile
- 24 January 2022
- Published by Taylor & Francis in Minimally Invasive Therapy & Allied Technologies
- Vol. 31 (5) , 803-809
Comparison of vNOTES technique with conventional laparoscopy in gynecological emergency cases
Vaginal natural orifice transluminal endoscopic surgery (vNOTES) has emerged as a minimally invasive approach. This study aimed to evaluate the feasibility and surgical outcomes of the vNOTES metho...
- 24 January 2022
- Published by Taylor & Francis in Minimally Invasive Therapy & Allied Technologies
- Vol. 31 (5) , 803-809
Comparison of vNOTES technique with conventional laparoscopy in gynecological emergency cases
Vaginal natural orifice transluminal endoscopic surgery (vNOTES) has emerged as a minimally invasive approach. This study aimed to evaluate the feasibility and surgical outcomes of the vNOTES metho...
- 4 August 2021
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (4) , 918-923
Comparison of Surgical Outcomes of Total Laparoscopic Hysterectomy and vNOTES Hysterectomy for Undescended-Enlarged Uteri
This study aimed to compare the surgical outcomes of laparoscopic hysterectomy (LH) and vaginally assisted natural orifice transluminal endoscopic surgery (vNOTES) hysterectomy procedures in women ...
- 4 August 2021
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (4) , 918-923
Comparison of Surgical Outcomes of Total Laparoscopic Hysterectomy and vNOTES Hysterectomy for Undescended-Enlarged Uteri
This study aimed to compare the surgical outcomes of laparoscopic hysterectomy (LH) and vaginally assisted natural orifice transluminal endoscopic surgery (vNOTES) hysterectomy procedures in women ...
- Top Cited Papers
- 26 May 2021
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (4) , 862-867
The Comparison of Surgical Outcomes following Laparoscopic Hysterectomy and vNOTES Hysterectomy in Obese Patients
This study aimed to compare the surgical outcomes of total laparoscopic hysterectomy (TLH) and vaginally assisted natural orifice transluminal endoscopic surgery (vNOTES) hysterectomy procedures in...
- 26 May 2021
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (4) , 862-867
Top Cited PapersThe Comparison of Surgical Outcomes following Laparoscopic Hysterectomy and vNOTES Hysterectomy in Obese Patients
This study aimed to compare the surgical outcomes of total laparoscopic hysterectomy (TLH) and vaginally assisted natural orifice transluminal endoscopic surgery (vNOTES) hysterectomy procedures in...
- Open Access
- 1 April 2021
- Published by Medknow in Gynecology and Minimally Invasive Therapy
- Vol. 10 (2) , 121-123
Hysteroscopic Removal of Intrauterine-retained Suture Material Causing Pelvic Inflammatory Disease
Retained intrauterine objects are rare causes of persistent vaginal discharge and pelvic inflammatory disease. Hysteroscopy is a minimally invasive technique used for removing these materials. A 47-year-old female who had recurrent vaginal discharge was admitted to our emergency department with pelvic pain. Retained nonabsorbable suture material was observed during her vaginal examination. After treating with intravenous antibiotics, operative hysteroscopy was performed, and the material was removed from the lower segment of the uterus.
- 1 April 2021
- Published by Medknow in Gynecology and Minimally Invasive Therapy
- Vol. 10 (2) , 121-123
Open AccessHysteroscopic Removal of Intrauterine-retained Suture Material Causing Pelvic Inflammatory Disease
Retained intrauterine objects are rare causes of persistent vaginal discharge and pelvic inflammatory disease. Hysteroscopy is a minimally invasive technique used for removing these materials. A 47-year-old female who had recurrent vaginal discharge was admitted to our emergency department with pelvic pain. Retained nonabsorbable suture material was observed during her vaginal examination. After treating with intravenous antibiotics, operative hysteroscopy was performed, and the material was removed from the lower segment of the uterus.
- Open Access
- 1 March 2021
- Published by Kare Publishing in European Archives of Medical Research
- Vol. 37 (1) , 11-14
Short-term Efficacy of Dienogest in Improving Pain in Patients with Endometriosis: A Single-center Experience
- 1 March 2021
- Published by Kare Publishing in European Archives of Medical Research
- Vol. 37 (1) , 11-14
Open AccessShort-term Efficacy of Dienogest in Improving Pain in Patients with Endometriosis: A Single-center Experience
- Open Access
- 1 January 2021
- Published by Medknow in Gynecology and Minimally Invasive Therapy
- Vol. 10 (1) , 30-36
Vaginal-assisted Laparoscopic Sacrohysteropexy and Vaginal Hysterectomy with Vaginal Vault Suspension for Advanced Uterine Prolapse
Objective: Vaginal-assisted laparoscopic sacrohysteropexy (VALH) is a new modified form of uterine-sparing prolapse surgery using a combined vaginal and laparoscopic approach. We aimed to compare 1 year efficacy and safety of VALH and vaginal hysterectomy with vaginal vault suspension (VH + VVS) in the surgical treatment of apical pelvic organ prolapse (POP). Materials and Methods: Women who requested surgical treatment for stage 2–4 symptomatic uterine prolapse were recommended to participate in one year-long randomized study between July 2017 and January 2019. POP Quantification (POP-Q) examination and validated questionnaires such as International Consultation on Incontinence Questionnaire Vaginal Symptoms (IVIQ-VS) survey, Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire Short Form (IIQ-7), and Patient Global Impression of Improvement (PGI-I) were recorded at baseline and 12 months after surgery. The main primary outcome measure was apical prolapse recurrence. Secondary results were duration of surgery, pain score, blood loss, postoperative hospital stay, and quality of life scores related to prolapse. Results: There were 15 women in VALH and 19 women in the VH + VVS group. ICIQ-VS score, ICIQ-QOL, UDI-6, and IIQ-7 scores were improved for both groups. According to the PGI-I scores, 80% of subjects in the VALH group, and 100% in the VH + VVS group, were “very much better” or “much better” with their prolapse symptoms at their 1-year follow-up. There was no reoperation or operation-related complication in both groups. Conclusion: VALH and VH + VVS have similar 1-year cure rates and patient satisfaction.
- 1 January 2021
- Published by Medknow in Gynecology and Minimally Invasive Therapy
- Vol. 10 (1) , 30-36
Open AccessVaginal-assisted Laparoscopic Sacrohysteropexy and Vaginal Hysterectomy with Vaginal Vault Suspension for Advanced Uterine Prolapse
Objective: Vaginal-assisted laparoscopic sacrohysteropexy (VALH) is a new modified form of uterine-sparing prolapse surgery using a combined vaginal and laparoscopic approach. We aimed to compare 1 year efficacy and safety of VALH and vaginal hysterectomy with vaginal vault suspension (VH + VVS) in the surgical treatment of apical pelvic organ prolapse (POP). Materials and Methods: Women who requested surgical treatment for stage 2–4 symptomatic uterine prolapse were recommended to participate in one year-long randomized study between July 2017 and January 2019. POP Quantification (POP-Q) examination and validated questionnaires such as International Consultation on Incontinence Questionnaire Vaginal Symptoms (IVIQ-VS) survey, Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire Short Form (IIQ-7), and Patient Global Impression of Improvement (PGI-I) were recorded at baseline and 12 months after surgery. The main primary outcome measure was apical prolapse recurrence. Secondary results were duration of surgery, pain score, blood loss, postoperative hospital stay, and quality of life scores related to prolapse. Results: There were 15 women in VALH and 19 women in the VH + VVS group. ICIQ-VS score, ICIQ-QOL, UDI-6, and IIQ-7 scores were improved for both groups. According to the PGI-I scores, 80% of subjects in the VALH group, and 100% in the VH + VVS group, were “very much better” or “much better” with their prolapse symptoms at their 1-year follow-up. There was no reoperation or operation-related complication in both groups. Conclusion: VALH and VH + VVS have similar 1-year cure rates and patient satisfaction.
- 10 December 2020
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 43 (2) , 99-106
Evaluation of genital self-image and sexual dysfunction in women with vulvar lichen planus or lichen sclerosus
Vulvar lichen planus (LP) and vulvar lichen sclerosus (LS) are chronic inflammatory diseases that affect women’s sexual health. In this study, our aim was to investigate sexual function, anxiety le...
- 10 December 2020
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 43 (2) , 99-106
Evaluation of genital self-image and sexual dysfunction in women with vulvar lichen planus or lichen sclerosus
Vulvar lichen planus (LP) and vulvar lichen sclerosus (LS) are chronic inflammatory diseases that affect women’s sexual health. In this study, our aim was to investigate sexual function, anxiety le...
- 19 October 2020
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 41 (5) , 815-820
The impact of cryotherapy for symptomatic cervical ectropion on female sexual function and quality of life
In rare cases, cervical ectropion causes symptoms such as abundant leucorrhoea, postcoital bleeding, recurrent cervicitis, pelvic pain, and dyspareunia. Cryotherapy is a commonly used treatment for symptomatic cervical ectropion. We assessed the impact of cryotherapy on sexual function and quality of life among patients with symptomatic cervical ectropion. In this prospective observational study, 73 patients were assessed before and six months after cryotherapy treatment using the Female Sexual Function Index (FSFI) and Short Form-12 Health Survey questionnaires. The double-freeze cryotherapy procedure was performed using a cryotherapy unit, and liquid nitrogen was used as a refrigerant. The mean physical and mental quality of life scores were significantly improved after treatment. With the exception of the pain domain, the overall and domain FSFI scores exhibited no significant differences before and after cryotherapy. The sexual pain domain scores were significantly increased after treatment. There was a statistically significant improvement in vaginal discharge, pelvic pain, and postcoital bleeding symptoms after the cryotherapy. We concluded that cryotherapy is an effective and feasible treatment for symptomatic cervical ectropion. Although cryotherapy results in improved quality of life scores, it has no significant impact on female sexual function.
- 19 October 2020
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 41 (5) , 815-820
The impact of cryotherapy for symptomatic cervical ectropion on female sexual function and quality of life
In rare cases, cervical ectropion causes symptoms such as abundant leucorrhoea, postcoital bleeding, recurrent cervicitis, pelvic pain, and dyspareunia. Cryotherapy is a commonly used treatment for symptomatic cervical ectropion. We assessed the impact of cryotherapy on sexual function and quality of life among patients with symptomatic cervical ectropion. In this prospective observational study, 73 patients were assessed before and six months after cryotherapy treatment using the Female Sexual Function Index (FSFI) and Short Form-12 Health Survey questionnaires. The double-freeze cryotherapy procedure was performed using a cryotherapy unit, and liquid nitrogen was used as a refrigerant. The mean physical and mental quality of life scores were significantly improved after treatment. With the exception of the pain domain, the overall and domain FSFI scores exhibited no significant differences before and after cryotherapy. The sexual pain domain scores were significantly increased after treatment. There was a statistically significant improvement in vaginal discharge, pelvic pain, and postcoital bleeding symptoms after the cryotherapy. We concluded that cryotherapy is an effective and feasible treatment for symptomatic cervical ectropion. Although cryotherapy results in improved quality of life scores, it has no significant impact on female sexual function.